Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:932-936
Published online before print April 20, 2009, doi: 10.1161/HYPERTENSIONAHA.109.129320
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Hypertension: June 2009, Volume 53, Number 6
Right arrow All Versions of this Article:
53/6/932    most recent
HYPERTENSIONAHA.109.129320v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Reynolds, R. M.
Right arrow Articles by Connell, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, R. M.
Right arrow Articles by Connell, J. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
*HYDROCORTISONE
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies

(Hypertension. 2009;53:932.)
© 2009 American Heart Association, Inc.


Original Articles

Programming of Hypertension

Associations of Plasma Aldosterone in Adult Men and Women With Birthweight, Cortisol, and Blood Pressure

Rebecca M. Reynolds; Brian R. Walker; David I. Phillips; Elaine M. Dennison; Robert Fraser; Scott M. Mackenzie; Eleanor Davies; John M. Connell

From the Endocrinology Unit (R.M.R., B.R.W.), Centre for Cardiovascular Sciences, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh; Medical Research Council Resource Centre (D.I.P., E.M.D.), University of Southampton, Southampton; and Glasgow Cardiovascular Research Centre (R.F., S.M.M., E.D., J.M.C.), University of Glasgow, Glasgow, UK.

Correspondence to Dr Rebecca Reynolds, Endocrinology Unit, Centre for Cardiovascular Sciences, Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. E-mail R.Reynolds{at}ed.ac.uk

Animal models suggest that explanations for the association of low birthweight with adult hypertension may include chronic activation of the hypothalamic-pituitary-adrenal or renin-angiotensin-aldosterone axes. In humans, low birthweight predicts elevated plasma cortisol, but associations with aldosterone have not been reported. We measured aldosterone in serum samples from 205 men and 106 women from 67 to 78 years of age, from Hertfordshire, UK, for whom birthweight was recorded. Participants underwent an overnight low-dose (0.25 mg) dexamethasone suppression test and a low-dose (1 µg) ACTH (corticotropin) stimulation test and were genotyped for the -344 C/T polymorphism of the CYP11B2 gene encoding aldosterone synthase. Median aldosterone was 6.22 ng/dL (range 0.15 to 38.74) and was higher in men than women (P<0.0001). Higher aldosterone levels after both dexamethasone and ACTH stimulation were associated with higher blood pressure (r=0.20, P=0.001; r=0.33, P<0.0001, respectively) and with lower birthweight (r=–0.16, P=0.008; r=–0.21, P=0.001, respectively). These associations remained significant after adjusting for age, gender, obesity, and genotype. Our findings supplement previous evidence that aldosterone is an important regulator of blood pressure and suggest that factors in early life that retard fetal growth and program activation of the hypothalamic-pituitary-adrenal axis in humans result not only in higher glucocorticoid activity but also in increased mineralocorticoid activity.


Key Words: programming • hypertension • aldosterone • mineralocorticoid • glucocorticoid